Iwamoto, F. M., Dalahmah, O. A., Buerki, R. A., Abbate, F., Gakuria, J., Rotolo, J., Haras, A. V. (2026). Lucicebtide (ST101) plus chemoradiation in newly diagnosed GBM patients: Efficacy, pharmacodynamics, and safety from phase 2 window-of-opportunity study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2079